C3 and ulcerative colitis: Patients with inflammatory bowel diseases (IBD), such as ulcerative colitis (UC) and Crohn’s disease (CD), show enhanced catabolism and deposition of C3 as well as circulating C3 conversion products at the site of inflammation8–10.